Concepedia

W. Chris Taylor

WC

10

Publications

1.9K

Citations

10

H-Index

1985

Active since

Affiliations

University of Manchester(Current)

Centre Hospitalier Universitaire de Besançon

UNC Lineberger Comprehensive Cancer Center

CRUK Lung Cancer Centre of Excellence

Centre Virchow-Villermé

W. Chris Taylor is an author at University of Manchester specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

1985–2019

10

Publications

10

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2018 · 599 citations · Full text

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2019 · 432 citations · Full text

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Helena Earl, Louise Hiller, Anne-Laure Vallier et al. · The Lancet · 2019 · 277 citations · Full text

Geriatric Assessment-Identified Deficits in Older Cancer Patients With Normal Performance Status

Trevor A. Jolly, Allison M. Deal, Kirsten A. Nyrop et al. · The Oncologist · 2015 · 225 citations · Full text

Feasibility of geriatric assessment in community oncology clinics

Grant R. Williams, Allison M. Deal, Trevor A. Jolly et al. · Journal of Geriatric Oncology · 2014 · 111 citations

, , +4

Rows per page

1–5 of 10